Pricing Log in Create free account
Wednesday 14 October 2026 Export ELV’s income statement to Excel — free account

Elevance Health, Inc.

ELV Healthcare Healthcare Plans

Elevance Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $199.1 billion, up 12.5% from fiscal 2024. In the quarter to June 2026, revenue grew 1.40%, EPS fell 13.1%, free cash flow fell 9.01% and total debt rose 4.08%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten; insiders bought in the last twelve months.

424.04 1.95 +0.46%
Market cap
$91.5B
P/E
18.8×
Fwd P/E
20.3×
Dividend yield
1.62%
F-score
6/9
Altman Z
3.09
Beneish M
−2.26
Dividend safety
96/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Elevance Health, Inc. (ELV) SEC filings, changes and red flags

Red flags

Filings

Form Period Filed What it reports Flags
8-K Sep 10, 2026 7.01 Regulation FD disclosure
10-Q Jun 30, 2026 P1I2: 26 added · 7 removed · 39 modified
P2I1A: no material changes, the filing says
8-K Jul 15, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jun 10, 2026 7.01 Regulation FD disclosure
8-K May 13, 2026 5.07 Submission of matters to a vote of security holders
10-Q Mar 31, 2026
8-K Apr 22, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Mar 10, 2026 7.01 Regulation FD disclosure
8-K Mar 2, 2026 8.01 Other events
8-K Feb 26, 2026 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure Officer departure
10-K Dec 31, 2025 1: 11 added · 7 removed · 90 modified
1A: 4 added · 3 removed · 84 modified
7: 20 added · 21 removed · 75 modified
8-K Jan 28, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Dec 10, 2025 5.02 Departure or appointment of directors or officers
8-K Nov 10, 2025 7.01 Regulation FD disclosure
10-Q Sep 30, 2025
8-K Oct 21, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Sep 8, 2025 8.01 Other events; 9.01 Financial statements and exhibits
8-K Sep 4, 2025 7.01 Regulation FD disclosure
10-Q Jun 30, 2025
10-K Dec 31, 2024

From the company’s filings on sec.gov. Red flags are raised by rules over the filings’ own data and text; they are not investment advice.